Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2011728490
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2011728490
Title / Product Name
ZUSAMMENSETZUNGEN VON 5-ETHYL-2-{4-[4-(4-TETRAZOL-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDIN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2011728490
EP Publication Number
2585048
E-Number
987245
Language
EN
PCT Number
US11040972
Publication Date
01.05.2013 A
11.04.2018 B1
Registration Date
11.04.2018
AT Publication Date
15.04.2018
Application Date
17.06.2011
Registration Number
-
Priorities
23.06.2010
US
357981 P
IPC
A61K 9/16 20060101AFI20170927BHEP
Maximum Duration of Protection
17.06.2031
Owner
CymaBay Therapeutics, Inc.
3876 Bay Center Place
Hayward, CA 94545
US
Representative
No representatives present
Inventor
MCWHERTER, Charles A.
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
MARTIN, Robert Louis
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
KARPF, David B.
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
ROBERTS, Brian K.
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
LORENZ, Douglas Alan
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
KETNER, Rodney James
c/o Metabolex Inc. 3876 Bay Center Place
Hayward, California 94545
US
see.ip - Details for ZUSAMMENSETZUNGEN VON 5-ETHYL-2-{4-[4-(4-TETRAZOL-1-YL-PHENOXYMETHYL)-THIAZOL-2-YL]-PIPERIDIN-1-YL}-PYRIMIDIN